Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health system learning enables generalist neuroimaging models.

Nature medicine·2026
Same author

Intelligent histology for tumor neurosurgery.

Neuro-oncology advances·2026
Same author

AI-driven label-free Raman spectromics for intraoperative spinal tumor assessment.

NPJ digital medicine·2026
Same author

Learning neuroimaging models from health system-scale data.

Nature biomedical engineering·2026
Same author

Health system learning achieves generalist neuroimaging models.

Research square·2025
Same author

Protocol to annotate and automate single-cell instance segmentation on stimulated Raman histology using deep learning.

STAR protocols·2025

Related Experiment Video

Updated: May 26, 2026

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

SIGNAL: A Scalable, Real-World Model for Rapid Intraoperative Molecular Classification of Gliomas Using Stimulated

Nicolas K Goff, John E Markert, David Reinecke

    Medrxiv : the Preprint Server for Health Sciences
    |May 25, 2026
    PubMed
    Summary

    A new machine learning model, SIGNAL, accurately classifies diffuse gliomas intraoperatively using stimulated Raman histology (SRH). This faster, lighter model with an attention mechanism outperforms previous methods on clinical data.

    More Related Videos

    Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
    09:09

    Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion

    Published on: April 12, 2020

    Real-Time, Two-Color Stimulated Raman Scattering Imaging of Mouse Brain for Tissue Diagnosis
    10:57

    Real-Time, Two-Color Stimulated Raman Scattering Imaging of Mouse Brain for Tissue Diagnosis

    Published on: February 1, 2022

    Related Experiment Videos

    Last Updated: May 26, 2026

    Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
    08:05

    Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

    Published on: June 10, 2025

    Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
    09:09

    Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion

    Published on: April 12, 2020

    Real-Time, Two-Color Stimulated Raman Scattering Imaging of Mouse Brain for Tissue Diagnosis
    10:57

    Real-Time, Two-Color Stimulated Raman Scattering Imaging of Mouse Brain for Tissue Diagnosis

    Published on: February 1, 2022

    Area of Science:

    • Neuro-oncology
    • Computational pathology
    • Medical imaging analysis

    Background:

    • Previous machine learning models for intraoperative glioma molecular prediction using stimulated Raman histology (SRH), like DeepGlioma, showed high accuracy on curated datasets but struggled with real-world clinical application due to slow processing and lack of image quality control.
    • DeepGlioma's large parameter count (162M) limited its intraoperative speed on existing SRH hardware, and its validation on curated images did not reflect the complexities of uncurated clinical data.

    Purpose of the Study:

    • To develop a novel, lightweight machine learning model for intraoperative molecular classification of diffuse gliomas using SRH.
    • To improve upon the performance and speed of existing models by incorporating an attention-based mechanism for image quality filtering.
    • To enable robust and generalizable intraoperative glioma classification on uncurated clinical datasets.

    Main Methods:

    • Developed SIGNAL (SRH-Informed Glioma classificatioN with Attention Learning), a 27M parameter model, using 1.56 million SRH images from 967 adult diffuse glioma patients.
    • Employed a ResNet50 backbone pre-trained with hierarchical contrastive loss, followed by a multi-head multi-layer perceptron (MLP).
    • Implemented a patch-based attention threshold (0.6) and a final MLP for predicting glioma subtypes and molecular status (IDH mutation, 1p19q codeletion, ATRX loss).

    Main Results:

    • SIGNAL achieved 90.10% overall accuracy in glioma subtype classification, significantly outperforming DeepGlioma (72.59%) and operating faster (16.0 vs. 6.7 patches/s).
    • SIGNAL demonstrated superior accuracy in molecular classification: IDH mutation (93.51% vs. 79.22%), 1p19q codeletion (93.51% vs. 88.31%), and ATRX loss (89.61% vs. 83.98%).
    • The attention mechanism effectively filtered low-quality patches (e.g., blood, acellular regions), showing strong correlation with cellularity and inverse correlation with blood coverage, while maintaining accuracy in tumor margins.

    Conclusions:

    • SIGNAL is a highly accurate and efficient lightweight model for intraoperative molecular classification of diffuse gliomas via SRH.
    • The integrated attention mechanism enhances robustness by filtering diagnostically uninformative image regions, crucial for reliable intraoperative decision-making.
    • SIGNAL offers a significant advancement for intraoperative glioma diagnosis, providing faster, more accurate, and interpretable results compared to previous state-of-the-art models.